United Therapeutics CEO trust sells 9,500 shares
The Chairperson & CEO's reported exercise and the trust's sales occurred under a pre-arranged Rule 10b5-1 plan adopted November 7, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
United Therapeutics Corp. (UTHR) Chairperson & CEO Martine A. Rothblatt reported that a family trust exercised 9,500 stock options at $117.76 per share on October 28, 2026, acquiring 9,500 common shares. The reported post-exercise option position was 138,410 options. The trust sold 9,500 shares in six transactions at weighted-average prices from $583.5017 to $588.3913 per share, under a pre-arranged Rule 10b5-1 trading plan adopted November 7, 2025.
Insider Trade Summary 10b5-1
Exercise and Sale: 9,500 shares ($4.44M approx. pre-tax spread)
Exercise and Sale
8 txns
Insider
ROTHBLATT MARTINE A
Role
Chairperson & CEO
Sold
9,500 shs ($5.56M)
Approx. gross sale proceeds
$5.56M
Approx. exercise cost
$1.12M
Approx. pre-tax spread
$4.44M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option F1, F12, F13 | 9,500 | $0.00 | $0.00 |
| Exercise | Common Stock F1, F2 | 9,500 | $117.76 | $1.12M |
| Sale | Common Stock F1, F3, F2 | 821 | $583.5017 | $479K |
| Sale | Common Stock F1, F4, F2 | 2,625 | $584.4314 | $1.53M |
| Sale | Common Stock F1, F5, F2 | 1,902 | $585.3585 | $1.11M |
| Sale | Common Stock F1, F6, F2 | 3,086 | $586.3694 | $1.81M |
| Sale | Common Stock F1, F7, F2 | 986 | $587.2653 | $579K |
| Sale | Common Stock F1, F8, F2 | 80 | $588.3913 | $47K |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock F9 | -- | -- | -- |
| Holding | Common Stock F10 | -- | -- | -- |
| Holding | Common Stock F11 | -- | -- | -- |
Holdings After Transaction:
Stock Option — 138,410 contracts (Indirect, by Trust);
Common Stock — 628,049 shares (Indirect, by Trust);
Common Stock — 40,513 shares (Direct);
Common Stock — 166 shares (Indirect, by Spouse)
Footnotes (13)
- F1. This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.
- F10. Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F11. Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F12. These stock options vested in equal one-third installments on March 15, 2021, 2022 and 2023.
- F13. Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.
- F2. Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F3. This transaction was executed in multiple trades at prices ranging from $582.91 to $583.88. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4. This transaction was executed in multiple trades at prices ranging from $583.92 to $584.91. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5. This transaction was executed in multiple trades at prices ranging from $584.92 to $585.89. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6. This transaction was executed in multiple trades at prices ranging from $585.95 to $586.93. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7. This transaction was executed in multiple trades at prices ranging from $586.96 to $587.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8. This transaction was executed in multiple trades at prices ranging from $588.00 to $588.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9. Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
Key Figures
Stock options exercised: 9,500 options
Exercise price: $117.76 per share
Common shares sold: 9,500 shares
+2 more
5 metrics
Stock options exercised
9,500 options
October 28, 2026
Exercise price
$117.76 per share
Options exercised on October 28, 2026
Common shares sold
9,500 shares
Six transactions on October 28, 2026
Weighted-average sale prices
$583.5017 to $588.3913 per share
Six reported sale transactions
Post-exercise stock-option position
138,410 options
Position reported following the exercise
Key Terms
pre-arranged 10b5-1 trading plan, weighted average price, one-third installments
3 terms
pre-arranged 10b5-1 trading plan regulatory
"pursuant to a pre-arranged 10b5-1 trading plan"
weighted average price financial
"The price reported above reflects the weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
one-third installments financial
"vested in equal one-third installments"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many UTHR stock options did Martine A. Rothblatt's family trust exercise?
A family trust exercised 9,500 options on October 28, 2026, at $117.76 per share and acquired 9,500 common shares. The reported post-exercise option position was 138,410 options.
When does the UTHR 10b5-1 plan end?
The pre-arranged plan continues until the earlier of the exercise of 1,734,410 stock options or December 31, 2026. The options covered by the plan expire March 15, 2027.
AI-generated analysis. How Rhea-AI works. Not financial advice.
